| 000 | 01550 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515055420.0 | ||
| 264 | 0 | _c20070629 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0707156 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPurohit, P G | |
| 245 | 0 | 0 |
_aThe role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cApr 2007 |
||
| 300 |
_a920-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBungarotoxins _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCholinergic Agents _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMuscles _xmetabolism |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeuromuscular Blocking Agents _xmetabolism |
| 650 | 0 | 4 |
_aOocytes _xmetabolism |
| 650 | 0 | 4 |
_aPhenylalanine _xgenetics |
| 650 | 0 | 4 |
_aProline _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xgenetics |
| 650 | 0 | 4 |
_aSerine _xgenetics |
| 650 | 0 | 4 |
_aVecuronium Bromide _xmetabolism |
| 650 | 0 | 4 | _aXenopus |
| 700 | 1 | _aTate, R J | |
| 700 | 1 | _aPow, E | |
| 700 | 1 | _aHill, D | |
| 700 | 1 | _aConnolly, J G | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 150 _gno. 7 _gp. 920-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0707156 _zAvailable from publisher's website |
| 999 |
_c16853637 _d16853637 |
||